GlassScriptPhysician profile
Risa Michelle Wolf
NPI 1033375670
$6,921.55
in general payments reported to CMS, 2019-2025
12 companies · $6,507 in 2025
The $6,507 reported for 2025 was more than what 86% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $39.98 · 2023: $223 · 2024: $152 · 2025: $6,507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,946 · Food and Beverage: $626 · Travel and Lodging: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,946.00 |
| Food and Beverage | $626.23 |
| Travel and Lodging | $309.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $6,420.15 | 2025 | |
| Mannkind Corporation | $297.18 | 2023-2024 | Afrezza |
| Sanofi-Aventis U.S. LLC | $66.82 | 2025 | |
| Abbott Laboratories | $64.06 | 2022-2024 | Freestyle Libre 3 |
| Insulet Corporation | $42.46 | 2023-2025 | Omnipod |
| Lilly USA, LLC | $16.74 | 2022 | |
| Beta Bionics, INC. | $14.14 | 2024 | Ilet Bionic Pancreas |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Risa Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.